The ZO-1 positive areas of IFN-β1a pre-treated cells, with or without HRV 16 infection, were similar to that of untreated, uninfected cells, showing that pre-treatment with IFN-β1a can protect TJs from HRV 16-inflicted damage. The gene discussed is TJP1; the disease is infection.